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A  variety of agents activate blast transformation and increase DNA synthesis in 
lymphocyte,  s, including phaseolus vulgaris phytohemagglutinin (PHA) 1 (1), concan- 
avalin A (Con A), sodium metaperiodate, trypsin, Hg  2+, Zn  2÷, and calcium ionophore 
A-23187  (reviewed  in  1,  2).  Because  the  activation  process  is  long  and  complex, 
involving a  large  number  of different  metabolic  processes,  a  number  of groups, 
including our own, have concentrated primarily on early activation events. Lympho- 
eytes undergo a number of metabolic changes within the 1st 15-20 min of stimulation, 
including increases in cyclic AMP, phosphatidylinositol turnover, protein phospho- 
rylation, and histone acetylation and phosphorylation; and increases in the transport 
of glucose, Ca  ++, and nueleosides (1). One metabolic process that might be involved 
in activation that has received little attention is fatty acid release from phospholipids. 
Mammalian cells contain several different phospholipid-cleaving enzymes including 
phospholipase A2 which acts selectively at the 2 position of the glycerol moiety of 
phospholipids releasing free fatty acids (3). Generation of arachidonic acid (AA) that 
is  esterified  primarily  at  the  2  position  of phospholipids  could  be  of particular 
significance because it is enzymatically converted to a  variety of biologically active 
fatty  acids  (for  example,  the  thromboxanes  and  prostaglandins)  which  may  be 
important in the control of cellular metabolism (4). Moreover, once fatty acids have 
been removed from phospholipids, reacylation can occur (3, 5), providing a  mecha- 
nism for changing the fatty acid composition of phospholipids and possible changes 
in membrane fluidity (6, 7). Some years ago, Resch and his colleagues (8) attempted 
to demonstrate increases in phospholipase activity in partially purified plasma-mem- 
brane preparations from human lymphocytes stimulated previously by lectin. When 
purified phosphatidylcholine was used as a substrate, lectin-activated cells showed no 
change in enzyme activity; although, with an erythrocyte plasma membrane substrate, 
a modest (up to 30%) increase in phosphatidylcholine-cleaving activity was seen. 
In  the present  report,  the possibility of early phospholipase  activation in  lectin- 
stimulated lymphocytes has been reexamined. Lymphocytes were preincubated with 
[3H] or [14C]fatty acids (particularly AA) to incorporate radioactivity into endogenous 
phospholipids and studied for release of radioactivity in response to lectin. Evidence 
* Supported by National Institutes  of Health Program Project Grant (Core) 1 PO1 AI 12450. 
1  Abbreviations used in this paper: AA, arachidonic acid; acyhransferase,  lymphocyte-acyl-CoA-lysophos- 
pholipid acyltransferase;  Con A, concanavalin  A; E-PHA, erythroagglutinating  PHA; P-PHA, a mixture 
of erythroagglutinating  and leukoagglutinating  PHA's; PHA, phaseolus vulgaris phytohemagglutinin. 
J. Exp. MED. © The Rockefeller  University  Press • 0022-1007/79/06/1487/17 $1.00  1487 
Volume 149  June 1979  1487-1503 1488  RELEASE  OF ARACHIDONIC ACID 
for the rapid release of sizable quantities  of AA  (and  to a  lesser extent,  other  fatty 
acids) from activated lymphocytes will be presented. 
Materials  and  Methods 
Reagents and Their Sources.  [1-14C]arachidonic acid ([14C]AA) (sp act 60 mCi/mmol, Amer- 
sham Corp., Arlington Heights, Ill.), and [3H]oleic acid (sp act 2.2 Ci/mmol, Amersham Corp.); 
phospholipids (Sigma Chemical Co., St. Louis, Mo.); fetal calf serum  (heated at 56°C for 30 
min  to  inactivate complement)  and  Eagle's medium  with  Earle's salts  (Gibco Diagnostics, 
Gibeo Invenex Div., Chagrin  Falls, Ohio);  unlabeled fatty acids (>99%  pure,  NuChek  Inc., 
Elysian,  Minn.);  phytohemagglutinin-P  (P-PHA),  a  mixture  of erythroagglutinating  and 
leukoagglutinating PHA's, Difco Laboratories, Detroit, Mich.), phytohemagglutinin-E (E-PHA, 
purified erythroagglutinating PHA, Burroughs Wellcome & Co., Greenville, N. C.), concana- 
valin A  (Con A, Sigma Chemical Co.), bovine serum albumin and  bovine gamma globulin 
(Sigma Chemical  Co.),  lipid-poor albumin  (Calbiochem-Behring Corp.,  American  Hoechst 
Corp.,  San  Diego,  Calif.), archidonyl CoA  (Avanti  Biochemicals, Inc.,  Birmingham,  Ala.). 
Human serum was obtained from the clotted blood of a donor with AB-positive erythrocytes, 
heated at 56°C for 30 rain and stored at -20°C.  Fatty acids were dissolved in hexane, dried, 
neutralized with Na2CO3 in water, and diluted in medium or buffer; the pH was adjusted to 
neutrality if necessary. 
Purified Cell Preparations.  Lymphocytes were purified from  250  or 500  ml  of heparinized 
human peripheral venous blood as described previously by dextran sedimentation followed by 
isopycnic centrifugation over a  mixture  of Ficoll (Pharmacia  Fine Chemicals  Inc.,  Div.  of 
Pharmacia Inc., Piscataway, N. J.) and Hypaque (Radiopaque Media, Winthrop Laboratories, 
New  York)  (9,  10). An  average  of 95%  of the  nucleated cells were  lymphocytes as judged 
morphologically after staining with Wright's stain and by the failure of the cells to ingest latex 
particles. Contamination of platelets and erythrocytes was minimal (less than one platelet or 
erythrocyte per two nucleated cells). In selected experiments, the few contaminating nucleated 
cells were removed by filtration through a 4-g nylon column (10),  providing a preparation in 
which 99-100% of the nucleated cells were lymphocytes. By immunofluorescence staining (11, 
12)  with a  mixture of rabbit anti-human  IgG, IgM, and  IgA antibodies, 9  _  4%  (SEM)  of 
filtered cells are B  lymphocytes as compared with  23  +  4%  (SEM)  of the  unfiltered cells. 
Because  50-80%  of the  lymphocytes were  lost  on  the  nylon,  this  procedure was  not  used 
routinely. 
Human  peripheral blood platelets (99% pure), polymorphonuclear leukocytes (>99% pure 
with >90%  neutrophiles, termed "neutrophiles," henceforth), and erythrocytes (>99%  pure) 
were obtained from human peripheral blood by previously described methods (13,  14). 
An  enriched  population  of human  monocytes  was  obtained  by  incubating  prelabeled, 
unfiltered lymphocytes (see below) in plastic Petri dishes (Fisher Scientific Co., St. Louis, Mo.) 
(15,  16) for 40 min and followed by washing to remove nonadherent cells. After the addition of 
Eagle's 2% AB serum, the adherent cells (-~75% monocytes) were evaluated for the release of 
radioactivity in response to PHA as described above for nonadherent cells, but the supernates 
were removed by aspiration instead of by centrifugation. 
Labeling  of Cells.  In  a  typical  experiment,  lymphocytes were  labeled  with  [14C]AA by 
incubation of a suspension of cells (1  ×  107 cells/ml) in Eagle's medium containing 2% (vol/ 
vol)  AB  serum  and  22.25  /~M  [14C]AA (22  x  I0  ~ cpm/ml  or 0.63  /lg/ml).  (The  [14C]AA 
concentration varied by as much as 25% with different cell preparations.) After the cells had 
been maintained for 60 min at 37°C, they were centrifuged at  120 g and washed three times 
with Eagle's 2% AB medium at room temperature. They were then resuspended in the same 
medium at a density of 1 ×  10 v cells/ml and used within 15 min for studies of [14C]AA release. 
Uptake of radioactivity was determined by counting  1 aliquot of sonicated cells in Scintiverse 
(Fisher Scientific Co.) on a Searle liquid scintillation counter (Searle Radiographics Inc., Des 
Plains, Ill.). Neutrophiles and erythrocytes were labeled under the usual conditions for labeling 
lymphocytes at  1 X  10 v cells/ml. Platelets were labeled in the final resuspension buffer used in 
the platelet purification (140 mM NaCI, 15 mM Tris, 5 mM glucose, pH 7.5) (13) at a density 
of 2  ×  109 cells/ml in the presence of [14C]AA, 4  ×  106 cpm/ml.  Erythrocytes were labeled 
under the same conditions as platelets with  the exception that  the incubation  medium was 
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Studies of AA Release.  Lymphocytes labeled with [14C]AA were ordinarily incubated in the 
final resuspension medium (Eagle's 2% AB medium, see above) in a total incubation vol of 0.27 
or  1.1  ml  for various time periods at  37°C  (usually  10 or  15  min). The  incubation mixture 
contained 0.1  vol of 0.1  M  NaCI  (control) or reagent (usually a  lectin) in 0.1  M  NaCI. Each 
experimental condition was evaluated in duplicate or triplicate. Some experiments were carried 
out in Gey's medium which is a balanced salt solution containing 0.9 mM CaCI2 and glucose 
(17).  After incubation, the cells were centrifuged for 2 min at 250 g at room temperature. The 
supernates were saved for counting and, frequently, chromatography. In experiments in which 
the cell pellets were also studied, the cells were washed two-three times with ice-cold, phosphate- 
buffered saline (0.15 M  NaCI and 0.01  M  PO4 =, pH 7.4) and extracted by the method of Bligh 
and Dwyer (18)  as modified by Masuzawa et al. (19).  In brief, the cell pellet was incubated 
with 3.8 ml of a mixture of CHCla:methanol:H20 (1:2:0:8) with or without 4 mM CaC12 for 30 
min at room temperature. The supernate was removed and 2.0 ml of a mixture of equal vol of 
CHCI3 and H~O was added. Aliquots from both the upper (aqueous) and lower (lipid) layers 
were removed, counted, and evaluated by thin layer chromatography. 
Thin Layer Chromatography.  Chromatography was performed in the presence and absence of 
unlabeled purified phospholipids and fatty acids as standards on silica-gel-G  plates (Brinkmann 
Instruments,  Inc.,  Westbury,  N.  Y.  or Arthur  H.  Thomas  Co.,  Philadelphia, Pa.)  at  room 
temperature  in  four different solvent systems, chloroform:methanol:13.5 M  ammonia:water 
(70:30:4:1, vol/vol/vol/vol) (20), solvent system C of Nugteren and Hazelhof (21), the organic 
phase  of ethyl  acetate:2,2,4-trimethylpentane: water  (50:100:100,  vol/vol/vol)  (22),  and  on 
argentaffin plates (prepared with silica gel G  equilibrated with 5% AgNOa) in ethyl acetate: 
methanol:isooctane:water (110:35:30:10:200, vol/vol/vol/vol/vol) (23). Areas containing lipids 
were identified by iodine staining, radioautography, radioactive scanning (Varian Associates, 
Instrument Div. Palo Alto, Calif.), or scraping and counting. In selected experiments, samples 
were also evaluated by two-dimensional thin layer chromatography in a system that provides 
a wider separation of phosphatidylinositol from phosphatidylserine and from phosphatidic acid 
than the one-dimensional systems (19). 
Absolute fatty acid concentrations were determined on supernates of stimulated and unstim- 
ulated cells by gas liquid chromatography  (24)  (Varian Associates, Instrument  Div., model 
3700)  on  a  50-cm  stainless steel column  packed with  5%  OV-101  on  chrom  G-HP  using a 
hydrogen flame ionization detector. Before gas liquid chromatography, samples were esterfied 
with diazomethane and partially purified by preparative thin layer chromatography in solvent 
system C. Aliquots were chromatographed in the presence and absence of an internal standard 
(8,  I1,  14-eicosatrienoic acid). 
Statistical analysis was by the two-tailed t test. 
Results 
Determination of Optimal Conditions  for Labeling Cells.  Initially, an attempt was made 
to define the optimal incubation conditions for the incorporation of radiolabel from 
[14C]AA into phospholipids, particularly phosphatidylinositol. In  three experiments 
under incorporation conditions similar to those described in the Methods section, but 
at a  somewhat  higher  [14C]AA concentration,  the overall uptake of [14C]AA by cells 
increased from 5%  (range 4-7%)  at 5 min to 50%  (range 45-53%)  at 60 min  (Fig.  1). 
Similar results were obtained  in  two experiments at  2  ×  105  cpm/ml  (not  shown). 
The largest amount of radioactivity was in phosphatidylcholine which contained 60% 
of the cell-bound radioactivity, whereas phosphatidylinositol contained  15-20% of the 
cell-bound radioactivity. Because the percentage of cell-bound radioactivity in phos- 
phatidylinositol was similar at 5  and 60 min  (17 and  16%, respectively, in this set of 
experiments) and a  longer incubation time than  1 h  did not appear to provide more 
efficient  utilization of label,  1  h  was  selected  as  the  standard  incubation  time  for 
labeling, although as shown below, other preincubation times were also studied. The 
ability to  rapidly incorporate  radioactive AA  into  lymphocyte phospholipids  is  in 
accord with previous studies in brain, platelets, and other tissues (3). 1490  RELEASE  OF  ARACHIDONIC  ACID 
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FI~.  1.  Effect of preincubation time on incorporation of [~4C]AA into total lymphocyte lipids and 
phosphatidylinositol; 50  X  l0  s lymphocytes (unfiltered) were suspended in Eagle's 2% AB serum 
and  incubated with  [14C]AA (1  X  106 cpm/ml)  for the indicated time periods; they were then 
washed three times and counted. Mean  -t- SEM of three experiments. 
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Fxo.  2.  Time course of release of radioactivity from prelabeled lymphocytes with P-PHA. Unfil- 
tered lymphocytes were prelabled with [14C]AA, washed three times and resuspended in 1 ml Eagle's 
2% AB serum at a cell density of 1 X  107/ml. Some of the cells were incubated directly at 37°C in 
the absence (open triangles) and presence (closed triangles) of P-PHA (20 p,g/ml) for the indicated 
time periods. Other cells were incubated further in medium at 37°C for 30 rain, washed, resuspended 
in medium at a  density of 1 x  l0  T cells/ml, and incubated at  37°C in the absence (open circles) 
and presence (closed circles) of PHA (20 ~g/ml). At the start of the incubation with lectin, 1 x  10  7 
cells contained an average of 117,000  cpm and  106,000  cpm, respectively. Mean  +  SEM of three 
experiments. PHA produced significant increases in release (P <  0.05)  at all of the early time points 
(30 min or less). In the experiment with preincubated and washed cells, a significant response was 
also obtained at later times. 
Release of Radioactivity from Prelabeled Lymphocytes.  When  prelabeled  cells  were 
washed  three  times  for  1-2  min  and  incubated  further  in  Eagle's  2%  AB  medium  at 
37°C  in  the  absence  of lectin,  "5%  of the  cell-bound  radioactivity  was  released  into 
the medium  (Fig.  2, open  triangles). A  further  slow release of cell-bound  radioactivity C.  PARKER,  J.  KELLY,  S.  FALKENHEIN,  AND  M.  HUBER 
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FIG.  3.  Effect  of prelabeling time on the release of radioactivity from prelabeled lymphocytes by 
PHA. Lymphocytes were prelabeled with [t4C]AA  as described in the legend to Fig. 1, washed, and 
incubated for 10 min at 37°C in the presence (open bars) and absence (closed bars) of P-PHA (20 
gg/ml) under the conditions given in the legend to Fig. 2. For the level of incorporation at the start 
of the incubation with PHA, see Fig. 1 (same three experiments). Mean  +  SEM is given. 
occurred over the next hour. PHA-P increased the amount of radioactivity in the cell 
supernate with changes occurring as early as 60 s  (Fig.  2, closed triangles).  (Because 
cells are centrifuged for 2 rain at the completion of the incubation, the rapidity of the 
early response may be somewhat  exaggerated.)  Phosphate-buffered  saline  washes of 
stimulated centrifuged cells also demonstrated increases in radioactivity but they were 
smaller  than  in  the  initial  supernates.  A  difference  between  PHA-stimulated  and 
control cells was demonstrable for at least 30 min after the addition oflectin, although 
the  most  marked  changes  were  in  the  first  10  min.  Some  of the  early  release  of 
radiolabel  in control cells may involve a  relatively  labile  pool of incorporated  fatty 
acid because incubating labeled, washed cells in medium at 37°C for 30 min, followed 
again by washing and incubation with  PHA, resulted  in considerably lower sponta- 
neous release  and  a  higher stimulation  ratio  with  PHA  (Fig.  2, closed circles  [open 
circles, without PHA]). 
In  cells  prelabeled  with  14C  for  30  and  120  min,  comparable  stimulation  ratios 
(PHA:control) for release of radioactivity were observed (Fig. 3). Significant responses 
were obtained with prelabeling times as short as 1 rain, although the stimulation ratio 
was  reduced,  suggesting  that  the  radiolabel  incorporated  at  this  time  is  not  as 
susceptible to release as at later times. 
The response to P-PHA was dose-related. In cells incubated for 10 rain with lectin, 
P-PHA  concentrations  as  low  as  0.6  /tg/ml  were  stimulatory,  although  the  most 
marked response was at 20-100 gg/ml P-PHA (Fig. 4).  Because binding equilibrium 
with PHA is not approached for many minutes  (25)  and is concentration-dependent, 1492  RELEASE OF ARACHIDONIC ACID 
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FxG. 4.  Dose  dependency of the release reaction to P-PHA. Prelabeled cells were incubated for 2 
(closed circles) or 10 (open circles) min at various concentrations of P-PHA at a final cell density of 
1 ×  10V/ml (83,400 cpm/ml). Mean ±  SEM of two experiments is given. 
the  greater response to low concentrations  to P-PHA at  10 min rather than at  1-2 
rain is easily explained, as is the greater effect of lectin concentration at early rather 
than at later times. The mitogenic optimum for P-PHA ranges from -1  to  10 #g/ml, 
depending on the culture conditions, but for metabolic changes occurring within the 
first several hours of the response, higher concentrations of lectin are ordinarily more 
effective (1). 
The rapidity of the release reaction to P-PHA suggested that the response was being 
produced at the lymphocyte surface, where receptors are available and cell activation 
is presumably initiated.  Since P-PHA readily agglutinates lymphocytes, even under 
relatively short incubation conditions, the possible role of agglutination in the response 
was  considered.  However, erythroagglutinating  PHA  (E-PHA),  which  agglutinates 
lymphocytes considerably less readily than P-PHA, was comparable to P-PHA in its 
potency as a releasing reagent with a response at concentrations as low as 0.8 #g/ml, 
even  in  short  incubation  experiments  (Table  I,  Eagle's  2%  medium).  Con  A,  a 
mitogenic lectin with a different carbohydrate binding specificity than PHA, also was 
stimulatory.  The  response  to  Con  A  was  almost  completely blocked  by a-methyl 
mannoside  (50  raM)  (Fig.  5),  a  monosaccharide  with  specificity  for  Con  A  that 
markedly  reduces  its  binding  to  cells.  By  contrast,  the  response  to  P-PHA  was 
unaffected  by a-methyl mannoside,  indicating  that  the  inhibition  is specific. Thus, 
the release reaction is initiated through specific carbohydrate sites on the cell surface 
and  agglutination,  per se, is probably not  required,  although  a  contributory  role is 
not excluded. 
Studies in  Filtered Lymphocytes.  Even  though  the  lymphocytes used  in  the  above 
studies were on average ---95% pure, < 10% of the cell-bound radioactivity was released 
by  the  various  stimuli  and  possible  contributions  by  contaminating  cells  in  the 
response had  to be considered.  In our initial  studies  with  filtered  (essentially pure) 
lymphocytes little or no increase in AA release was obtained with PoPHA. However, 
filtration through nylon has been reported to nonspecifically alter both lymphocytes 
and polymorphonuclear leukocytes (26,  27).  Although it is clear that filtered lympho- C.  PARKER, J.  KELLY,  S.  FALKENHEIN, AND M.  HUBER 
TABLE  I 
Release of Radioactivity by PHA from Prelabeled Lymphocytes in  Various Media 
1493 
Medium  Control 
E-PHA 
20 #g/ml  4 #g/ml  0.8 #g/ml  0.16 #g/ 
ml 
cpm 
Eagle's 2% AB  4,490  8,280:1:  5,738:1:  5,134§  4,268 
Gey's  3,354  4,936:1:  3,420  3,442  3,024 
Gey's, no Ca ++  3,422  3,776  3,310  3,030  3,114 
Gey's, EGTA,* no Ca ++  3,080  3,218  3,246  3,132  2,798 
Gey's, 0.3% wt/vol, albumin  4,850  10,670:[:  7,734:~  5,650§  5,236 
Washed, unfiltered lymphocytes labeled with [14C]AA (6.72 ×  105 cpm/107 cells) were incubated in  1.1 
ml of the indicated medium for 10 rain at 37°C in the presence  and absence of E-PHA at a cell density 
of 8.5  x  10  n cells/ml. 
* Mean of three experiments, 1 mM EGTA. 
:1: Statistically higher than PHA alone (P <  0.03). 
§ Statistically higher than PHA alone (P <  0.05). 
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Fla.  5.  Release of radioactivity from prelabeled lymphocytes in the presence  and absence of Con 
A and a-methyl mannoside. Conditions for incubation of cells with lectin were the same as those 
given in the legend to Fig. 3. At the start of the incubation with lectin,  labeled cells contained an 
average of 94,150 cpm. Mean  +  SEM is given. Open bars, Con A alone; closed bars, Con A  +  a- 
methyl mannoside (50 mM). Spontaneous release was 6,200 cpm and was unaffected by a-methyl 
mannoside. 50 mM N-acetylglucosamine failed to diminish the increase  in release with Con A (not 
shown). 
cytes  are  subject  to  mitogenic  activation  they  might,  nonetheless,  be  temporarily 
damaged,  helping explain  their failure to release AA rapidly  in response  to PHA.  In 
accord with  this possibility,  when  filtered lymphocytes were allowed  to "recover" by 
incubation  at 37°C in Eagle's 2% AB medium  for 2 h  before exposure to []4C]AA and 
then labeled in the usual way, a  response to P-PHA  was again demonstrable  (usually 
at  about  30-50%  of the  level  seen  in  unfiltered  cells,  Table  II).  When  unlabeled, 
unfiltered  cells  were  added  to  labeled,  filtered  cells,  responses  to  lectin  were  not 
enhanced,  suggesting that  reduced  response was not due to the loss of contaminating 1494  RELEASE OF ARACHIDONIC  ACID 
TABLE II 
Release of Radioactivity  by PHA from Filtered and  Unfiltered  Lymphocytes 
Time after 
filtration be-  Labeling  Cells/107  P-PHA increase 
time  cells  above control*  fore labeling 
Unfiltered cells 
Filtered cells 
rain  rain  cpm ×  I0 -4  % 
--  60  83  89  +  9:~ 
0  60  44  8 ±  7 
0  15  15  7 +  4 
120  60  53  38 ±  5~ 
1,080  60  45  29 +  10§ 
Unfiltered lymphocytes were prepared, labeled, and evaluated for release of radio- 
activity as described in the legend to Fig. 2 with the exception that the incubation 
vol was 0.25 ml (because of limitations in cell number) and P-PHA concentrations 
of 4.0, 0.8, and 0.2/~g/ml, as well as 20 #g/ml, were examined. The remainder of 
the cells were filtered, labeled immediately for either 15 or 60 min, or resuspended 
in sterile medium and incubated for 120 or 1,080 rain before labeling. They were 
then evaluated for release of radioactivity into the supernate by PHA as described 
for filtered cells. Mean ±  SEM of three experiments, each comparing filtered and 
unfiltered lymphocytes from the same donor. 
* Presented as the largest response seen at  any of the PHA concentrations (in all 
instances, 20 p,g/ml P-PHA). 
:~ Significantly higher than control (P <  0.02); significant increases (P <  0.05) also 
occurred at 4 and 0.8 ~g P-PHA/ml. 
§ Significantly higher than control (P < 0.05); a significant increase also occurred at 
4/tg P-PHA/ml. 
cells  (neutrophiles  or  monocytes)  that  interact  with  lectins  and,  under  favorable 
circumstances, promote  lymphocyte activation (1).  Incubating the  filtered cells for 
longer periods (up to  16 h)  at 37°C in sterile Eagle's 2% AB medium (Table II) or in 
RPMI  medium supplemented with  pyruvate  and  glutamine (not  shown)  did  not 
further increase the response. 
Studies in Other Cell Types.  The reason for the decreased AA response in filtered, as 
compared with unfiltered, lymphocytes is not presently clear. The possibility is not 
excluded that the cells fail to recover completely from the nylon filtration step, even 
when incubated for long periods. Another possible explanation, that contaminating 
cells enhance the response by lymphocytes by binding the lectin and by presenting it 
in  the  proper  perspective  to  lymphocytes,  seems  unlikely  because  in  the  three 
experiments in which this possibility was evaluated, unlabeled, unfiltered lymphocytes 
failed to enhance release from labeled, filtered lymphocytes. Alternatively, in as much 
as the contaminating cells themselves are stimulated metabolically by lectins (28, 29) 
and they presumably contain [14C]AA label, some of the release AA may be coming 
from these cells. However, in studies with prelabeled platelets and neutrophiles, little 
or  no  increase in AA release  in response to  PHA  was  seen  (Table III).  Moreover, 
erythrocytes incorporated very little radiolabel even when preincubated at unusually 
high 14C concentrations and also failed to respond to PHA (not shown). Thus, based 
on  the  available evidence in the  numbers present  in our  lymphocyte preparation, 
platelets, granulocytes, and erythrocytes probably do not contribute significantly to 
the response. In four experiments with mononuclear cells adherent to plastic (predom- 
inately  monocytes  and,  to  a  lesser  extent,  B  lymphocytes,  T  lymphocytes,  and 
neutrophiles) there was significant release of radioactivity to response to PHA in two C.  PARKER, J.  KELLY,  S.  FALKENHEIN, AND M.  HUBER 
TABLE III 
Release of Radioactivity from Prelabeled  Platelets and Neutrophiles 
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P-PHA 
Cell type 
Control  20 pg/ml  4 #g/ml  0.8 pg/ml 
cpm 
Platelets  8,426 ±  204  8,862  ±  176  8,498  ±  312  8,266  ±  264 
Neutrophiles  2,040 ±  112  2,096  ±  102  1,878  ±  38  1,812 ±  74 
Labeled,  washed  platelets (see text)  containing  3.85  ×  104  cpm/10  a cells were 
suspended in Eagle's 2% AB serum at a density of 2 ×  10  a cells/ml and incubated in 
the presence and absence of P-PHA for 15 rain at 37°C. Labeled, washed neutrophiles 
(7.6 ×  104 cpm/107 cells) were resuspended at 1 ×  107 cells/ml in Eagle's 2% serum 
and incubated as described for platelets. Mean ~  SEM of two experiments with each 
of the cell types. (None of the changes is statistically significant.) Labeled, unfiltered 
lymphocytes from the same cell donor were incubated under identical conditions and 
significant  increases in  medium  radioactivity were shown to occur at at least two 
concentrations of PHA. Platelets were also studied in Eagle's medium without serum 
and the final platelet resuspension medium (14) with similar results. 
(not shown).  However, even  in the positive experiments, the response  (on a  per cell 
basis)  was  <50%  of that  in  the  filtered cells. Thus,  while  nylon  filtration removes 
monocytes and  partially depletes B-lymphocyte subpopulations in lymphocytes (10, 
30),  the  major effect  is probably on  the T  lymphocytes themselves  that  appear  to 
account  for  the  majority  of  the  response.  Nonetheless,  the  possibility cannot  be 
excluded that monocytes respond more effectively in suspension than when attached 
to the dishes. 
Release in Different Media.  Table I  also illustrates the considerable variation in the 
release reaction in different media. There was a  marked reduction of the response in 
Gey's balanced salt solution and  no response at  all in Gey's solution without  Ca ++, 
both in the presence and absence of EGTA, indicating that Ca  ++ must be present in 
the medium to obtain a response. By contrast, in Gey's solution containing both Ca ++ 
and bovine serum albumin  (either dialysed or undialysed), the response was as good 
or better than  in Eagle's 2% AB serum.  Bovine gamma  globulin, which binds lipids 
to a  much lesser extent than bovine serum albumin, had little or no enhancing effect 
on release (not shown). 
Effect  of Various Fatty Acids.  The  improved response in Gey's medium  containing 
albumin  compared  to  Gey's medium  alone  raised  the  possibility that  the  albumin 
might be enhancing the response by binding released AA, and reducing reuptake by 
cells.  In  accord  with  this  possibility, the  addition  of lipid-poor albumin  to  Gey's 
solution  increased the release of radioactivity in  response  to  PHA.  There  were  also 
less-marked effects on basal AA release and on uptake of [3H]AA, added at the same 
time as lectin. Thus,  the enhancing effect of albumin on  [14C]AA release is probably 
due to trapping of released AA. Serum albumins are known  to contain binding sites 
which interact effectively with long-chain fatty acids. 
The effect of exogenous fatty acids on release also was studied. Various fatty acids 
were added to ordinary Eagles 2% AB medium or Gey's solution; AA and, probably, 
8,1 1,14-eicosatrienoic acid, but not other long-chain fatty acids; increased the release 
of radioactivity  (Table  IV)  (Shown  for  Eagle's  2%  AB  serum  only).  Various  AA 
analogues,  including  arachidonylmethylester  and  arachidonyl  CoA  were  inactive 1496  RELEASE OF  ARACHIDONIC ACID 
TABLE IV 
Effect of AA and Other Fatty Acids on Release of Radioactivity from Prelabeled Lymphocytes 
cpm released 
Percentage  Percentage 
of increase  of increase 
above no  above in- 
PHA con-  crease with 
trol  PHA alone 
%  % 
Control  4,058  -  200 
PHA-P, 4 #g/ml  6,622  +  276  63 
+  AA, 10#M  9,024  +  271"  121  9l 
+  AA, ! #M  8,568  +  330*  110  75 
+  Stearic acid, 10 #M  6,720  +  201  65  3 
+  Stearic acid, 1/~M  6,518  +  823  60  0 
+  Palmitic acid, 10#M  6,814  +  173  68  7 
+  Palmitic acid, 1 #M  6,448  +  331  59  0 
+  Oleic acid,  10#M  6,570  +  414  61  0 
+  Oleic acid, 1 #M  6,612  -  217  63  0 
+  Linoleic acid, 10 #M  7,022 _+ 086  73  16 
+  Linoleic acid, 1 #M  6,876  +  824  69  9 
+  Linolenic acid, 10/zM  6,018  ±  507  49  0 
+  Linolenic acid, I#M  6,418  +  628  58  0 
+  Eicosatrienoic  acid, 10 #M  7,768 +  376*  92  46 
+  Eicosatrienoic  acid, 1 #M  7,124 ±  304  76  20 
Washed,  unfiltered  lymphocytes labeled  with  [14C]AA 1.2  x  105  cpm/10  7 cells)  were 
incubated for 15 min at 37°C in 0.8 ml of Eagle's 2% AB serum medium at a cell density 
of 8 ×  106/ml in the presence and absence of P-PHA (4 #g/ml), AA or another long-chain 
fatty acid. Mean  +  SEM of three experiments. 
* Statistically higher than PHA alone (P <  0.02). 
* Statistically higher than PHA alone (P <  0.05). 
(Table  V).  Thus,  to  effectively enhance  release  (or  prevent  reuptake)  of AA, a  fatty 
acid with a  free carboxylic acid  group  and  >  18 carbons  is needed.  Even the loss of a 
single  double  bond  at  the  5  position  (in  going  from  AA  [5,8,11,14-eicosatetraenoic 
acid]  to  8,11,14-eicosatrienoic  acid)  is  associated  with  a  considerable  diminution  of 
the response. 
The  basis  for the effect of AA is  uncertain.  Certainly,  AA is being  taken  up  from 
medium  into  phospholipids  and  would  be expected  to  gradually  exchange with  cell- 
bound  AA.  However,  in  three  experiments  in  which  cells  were  prelabeled  with 
[14C]AA, little or no effect of the lectin on [aH]AA uptake by cells was observed. Thus, 
under  the conditions  of our experiments,  PHA  did  not  appear  to  be promoting  the 
exchange of cellular AA with AA in the medium.  Moreover, in the absence  of lectin, 
exogenous AA, at  best,  only  modestly  increased  the  accumulation  of [14C]AA  in  the 
medium  (a  mean  increase  of  15  +  8%  [SEMI  in  six  experiments).  Exchange  alone 
could not  be the sole basis  for release of cell-bound  radioactivity in any case because 
the absolute amount  of arachidonate  in the medium  is increased by lectin (see below). 
Studies  of Phospholipids.  To  determine  the  source  of  the  released  /'adioactivity, 
lymphocytes  that  had  been  stimulated  with  PHA  were  extracted  and  the  major 
intracellular  lipids containing  radioactivity were separated  by  thin  layer chromatog- 
raphy.  In  four experiments,  there  was  a  40%  decrease  in  phosphatidylinositol  radio- 
activity  as  compared  with  little or  no  change  in  phosphatidylcholine  or  phosphati- C.  PARKER, J.  KELLY,  S.  FALKENHEIN, AND M.  HUBER 
TABLE V 
Effect of A A and its Analogues on Release of Radioactivity  from Prelabeled Lymphocytes 
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cpm released 
Percentage 
Percentage  of increase 
of increase 
over in- 
above no 
crease with 
PHA control 
PHA alone 
%  % 
Control  3,162  +  140 
P-PHA, 4 #g/ml  5,522 :tz 205  75 
+  AA, 10#M  7,156 +  262*  137  82 
+  AA, 1 #M  6,540 +  165"  108  44 
+  Arachidonyl alcohol, 10 #M  5,648 +  428  77  3 
+  Arachidonyl alcohol, 1 #M  5,554 +  132  75  0 
+  Arachidonyl CoA, 10 #M  5,348 +  376  69  0 
+  Arachidonyl CoA, 1 #M  5,550 -+ 225  76  1 
+  Arachidonyl OMe, l0 #M  5,698 :t:  198  80  6 
+  Arachidonyl OMe,  1 #M  5,162 +  478  64  0 
Washed,  unfiltered  lymphocytes  labeled with  [14C]AA (8.8  ×  105 cpm/107  cells) were 
incubated for 15 min at 37°C in 0.8 ml of Eagle's 2% AB serum medium at a cell density 
of 8  ×  106 cells/ml in  the presence and absence of P-PHA (4 #g/ml), AA, or an AA 
analogue. Mean  +  SEM of two experiments. 
* Statistically higher than P-PHA alone (P < 0.02). 
dylethanolamine  radioactivity (Table VI).  Phosphatidic  acid and  AA radioactivity 
were  increased  but  accounted  for  only  a  small  percentage  of the  total.  Losses  of 
radioactivity from phosphatidylinositol could account for at least 70% of the increase 
in arachidonate radioactivity seen in supernates of PHA-stimulated cells (Table VI). 
However, other phospholipids and triglycerides are not excluded as significant sources 
of released AA. 
Characterization  of the Released  Radioactivity.  To  determine the nature of the released 
radioactivity, supernates and washes of PHA-stimulated cells were chromatographed 
in four different solvent systems. In all of these systems >70% of the 14C radioactivity 
in  the  supernate  comigrated  with  reference  long-chain  fatty  acids  (arachidonic, 
linolenic,  and  oleic  acids,  which  have  the  same  Rf's  in  these  systems).  Washed, 
extracted cells exposed previously to lectin also contained increased quantities of fatty 
acid radioactivity, although the amount  was <10% of that in the supernate.  Consid- 
ering that  the original label was  [14C]AA and that even  very short prelabeling times 
were associated with subsequent release of radioactivity into the supernate with PHA, 
it seemed likely that much or all of the released radioactivity in fatty acid was in AA 
itself.  This  was  confirmed  by  argentaffin  thin  layer chromatography  (not  shown) 
which  separates  long-chain  fatty acids on  the  basis of their  degree of unsaturation 
(23). 
Quantitative  Studies  of Unlabeled Fatty Acid Release.  The release of AA by PHA was 
also  shown  by  quantitative  gas  liquid  chromatography  measurements  on  partially 
purified supernates of stimulated and unstimulated lymphocytes incubated in medium 
with lipid-poor albumin to keep the fatty acid content of the medium to a  minimum. 
P-PHA  (20 g/ml,  10 min at  37°C)  produced an approximately eightfold increase in 
the amount  of AA in the supernates  (Table VII). Smaller increases occurred in C16: 
1, C16:0, and C18:1  fatty acids. (C16:0 and C16:1  are not completely resolved on our 1498  RELEASE  OF  ARACHIDONIC  ACID 
TABLE  VI 
Effect of Stimulation of Lectin on Lipid Radioactivity 
Percentage  Percentage 
Lipid fraction  Control cpm  of pellet  P-PHA cpm*  of pellet 
counts*  counts* 
Pellet  Total:j:  85,998  +  5,381  79,100  ±  4,610 
Phosphatidyl-  44,800  ±  2,120  58.5  42,500  :t:  2,066  61.2 
choline 
Phosphatidyl-  11,712  ±  408  15.3  7,108  ±  27611  10.2 
inositol§ 
Phosphatidyl-  14,800  ±  411  17.2  14,211  ±  129  20.4 
ethanola- 
mine 
Phosphatidic  472  ±  30  0.55  729  ±  14  0.92 
acid 
Free AA  121  ±  42  0.14  277  ±  44  0.35 
Triglyceride  1,208  .4-  118  1.4  1,178  ±  42  1.5 
Supernate  5,920  ±  376  11,315  ±  30011 
For incubation conditions, see legend to Fig. 2. Before incubation with lectin, the cells contained 91,120 
+  4,864 epm/107 cells. At the completion of the incubation, the cells and the supernates were separated. 
The cells were extracted as described in the text and the organic phase was chromatographed on silicic 
acid  plates  with  chloroform:methanol:13.5  M  ammonia:water  (70:30:4:1)  as  the  developing solvent, 
together with known phospholipid standards. Lipid-containing bands were localized with I2 vapor, eluted, 
and counted. Mean  ±  SEM of four experiments. 
* Based on the radioactivity present in the organic phase at  the completion of the extraction procedure 
which was 76,500  ±  4,961  and 69,624  ±  3,205 cpm in control and PHA-stlmulated cells, respectively. 
:~ The total radioactivity in the pellet at the completion of the incubation is given. 
§ Although phosphatidylinositol and phosphatidylserine comigrate in the above solvent system, in two of 
four experiments, two-dimensional thin layer chromatography was performed and 90% of the counts in 
these two phospholipids and all of the change in radioactivity with PHA was shown to be in phosphati- 
dylinositol. 
II Statistically different from control (P <  0.01). 
TABLE  VII 
Gas Liquid Chromatographic Analysis of Fatty Acid Release 
Fatty acid 
Fatty acid (mean +  SEM) 
Control  PHA 
rig~ 107 cells 
C16:0, C16:1  28  ±  8  48  ±  4 
C18:0  28  "+  5  34  +  3 
C18:1  40  ±  10  130  ±  11 
C20:4  28  ±  10  220  ±  10 
Unfiltered lymphocytes were labeled with [14C]AA, washed, incubated 30 min 
at  37°C  in  Eagle's 2%  AB, washed again, suspended in Gey's medium with 
lipid-poor  bovine  serum  albumin  (2.5  mg/ml)  at  2  ×  107  cells/ml  and 
incubated in triplicate  in a  total  vol of 7.0 ml with and without P-PHA  (20 
#g/ml)  for  10 min at  37°C.  Fatty  acids were  extracted,  esterified,  partially 
purified by thin layer chromatography, and analyzed by liquid chromatogra- 
phy in the presence and absence of 8,11,14-eicosatrienoic acid as described in 
the text. C16:0 and C16:1  were not completely resolved on our columns and 
are therefore expressed as a  total. However, results with internal and external 
standards  indicate  that  at  least  90%  of  the  signal  in  this  region  of  the 
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columns, but at least 90% of the signal appeared to be from C 16:0.) Thus, the release 
reaction  was  partially,  but  by  no  means  completely, selective by AA.  To  further 
evaluate the selectivity of release, cells were prelabeled with  [aH]oleic acid together 
with  [a4C]AA,  and  stimulated  with  PHA.  While  a  small  increase  in  release of aH 
(oleate) radioactivity was observed in two of three experiments, it was considerably 
smaller than that seen with the [14C]AA (not shown). 
Discussion 
From the results of these studies, it is clear that preparations of human peripheral 
blood lymphocytes release AA and, to a lesser extent, other fatty acids in response to 
PHA  or  Con  A,  and  that  a  substantial  part  of the  response  is  in  lymphocytes 
themselves, rather than in contaminating cells. Much of the release of [14C]AA was 
from phosphatidylinositol which lost up to 40% of its AA label. Because the amount 
of [a4C]arachidonate  released  is  small  relative  to  the  total  cell  [14C]arachidonate 
content, other sources, particularly phosphatidylcholine and  phosphatidylethanola- 
mine, cannot be excluded. Because AA is selectively incorporated into the 2 position 
of phospholipids,  the  rapid  release  of AA  could  be,  at  least  in  part,  through  the 
activation of phospholipase A2. However, quantitative measurements of phospholipids 
and  a  direct  demonstration  that  lysophospholipids  are  being  generated  would  be 
needed to establish this mechanism. Because the role of phospholipase is uncertain, it 
is not clear how our findings relate to the earlier work of Resch and his colleagues (8) 
in a  different assay system in which plasma membranes from lectin-stimulated cells 
underwent  small  increases  in  phospholipase  activity  for  phosphatidyl-choline  in 
erythrocyte ghosts, but not for free phosphatidylcholine. An equally, or more, attrac- 
tive explanation  for our observations  is  that  phospholipids  are  being degraded  by 
phospholipase C  to diacylglycerol which is subsequently deacylated to provide free 
fatty acid.  Phospholipase C  has been demonstrated in pig lymph node lymphocytes 
by  Allan  and  Michell  (31).  Studies  in  immunologically and  nonimmunologically 
stimulated  rat  mast  cells  by  D.  Kennerly in  our  laboratory strongly support  this 
mechanism as an important source of released fatty acid. 2 The diacylglycerol pathway 
could better explain the partial selectivity of the release reaction for AA. Although it 
is apparent  that  other fatty acids are also being released, a  major contribution by 
other lipases  appears  less  likely. While  mono-, di-, and  triacylglycerides as well  as 
esterified cholesterol contain AA, based on quantitative thin layer chromatography 
studies (presented for triglyceride), they do not appear to be quantitatively important 
sources  of released  radioactive  AA,  at  least  under  the  relatively short  incubation 
conditions used in our experiments. Because PHA and Con A bind to the cell surface, 
it  seems  likely that  much of the  fatty acid  release  is  from the  plasma  membrane. 
However, if this is true and phosphatidylinositol is the major source, the magnitude 
of the phosphatidylinositol-cleavage reaction is somewhat surprising considering that 
phosphatidylinositol has been reported to be present in sizable quantities in the Golgi 
apparatus, endoplasmic reticulum, mitochondria, and nuclear membranes, as well as 
in plasma membranes (3, 5). 
One  consistent  observation  in  this  study was  that  release of fatty acid  into  the 
medium was considerably greater in serum-containing medium (usually 2% AB serum 
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in Eagle's medium)  than in media without added serum.  Even though unextracted 
serum contains AA, and unlabeled AA augmented the release of fatty acid,  1/IM or 
higher concentrations were required, whereas the concentration of AA in 2% serum is 
probably <20 nM  (32).  Moreover, dialysed lipid-poor albumin was also stimulatory, 
suggesting that much of the effect of serum may involve the serum proteins themselves, 
presumably through  their ability to bind  released AA and  prevent its reuptake by 
cells. A similar mechanism has been suggested for albumin effects on fatty acid release 
by thrombin in human platelets (20). 
As far as the basis for the stimulation of release by AA itself is concerned, because 
lectins stimulate lymphocyte-acyl-CoA-lysophospholipid  acyltransferase (acyltransfer- 
ase)  (33),  an  enzyme promoting  the  reacylation of lysophospholipids,  perhaps  the 
simplest explanation is that the unlabeled AA is competing with released [14C]AA for 
reuptake by cells. If this is the explanation, the inability of AA CoA, the presumed 
intermediate in reacylation of lysophospholipids, to promote the accumulation of AA 
in  the  medium  is somewhat  surprising.  But  instability or failure to penetrate into 
appropriate areas of the cell may be a problem. A more difficult question is why other 
unlabeled  fatty  acids  are  so  much  less  effective in  promoting  the  release  of 14C 
radioactivity than AA because they are also substrates for the acyhransferase. How- 
ever, juding from previous studies in broken lymphocyte preparations (33), AA CoA 
has  a  20-fold  higher  affinity  for  the  acyltransferase  than  oleyl  CoA.  If similar 
differences exist for the other fatty acids, AA should have considerable selectivity for 
the enzyme. 
In view of the recently demonstrated importance of AA as a precursor for a variety 
of biologically active lipids, one might speculate as to the importance of the early AA 
release reaction in the activation process. As will  be presented in detail elsewhere,  3 
other mitogens for human lymphocytes including ionophore A-23187, sodium meta- 
periodate, trypsin, HgCI2, and pokeweed also stimulate the release of AA from human 
lymphocytes, strengthening the argument that AA release is involved in some way in 
the activation process. Much of the metabolism of AA in mammalian cells is initiated 
through one of two enzyme systems: fatty-acid lipoxygenase or a cyclooxygenase (4). 
Indomethacin and aspirin which inhibit the cyclooxygenase are moderately effective 
inhibitors of mitogenesis in human  lymphocytes, whereas 5,8,11,14-eicosatetraenoic 
acid, a triple-unsaturated analogue of AA, which inhibits both the lipoxygenase and 
the cyclooxygenase, is  a  potent  inhibitor  (inhibition approaching  100% at  low #M 
concentrations)  (34).  Moreover, low concentrations  (0.13-10/IM)  of exogenous AA 
considerably enhance mitogenesis both in lipid-poor media and in media containing 
10% fetal calf serum.  Finally, while previous studies suggest that  increases in prosta- 
glandin synthesis are delayed for many hours in lectin-stimulated human mononuclear 
cells (35), recent work in our laboratory indicates that metabolites of AA are present 
in increased quantities very soon after exposure to lectin. Because AA availability is 
rate-limiting in prostaglandin synthesis in many tissues, the initial site of stimulation 
may  be  the  release  of free  fatty  acid.  If AA  metabolizing  enzymes exist  in  close 
anatomic relationship to enzymes involved in AA release, local concentrations of AA 
much higher than those in the cells as a whole might be generated. Because activated 
lymphocytes also  exhibit  increased  acyltransferase activity, and  the  affinity of the 
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enzyme for AA is high (33), resynthesis of phospholipid may be occurring, providing 
additional substrate for AA release and metabolism. 
In addition  to the possible utilization  of released AA as a  substrate,  the removal 
and reuptake of fatty acids provides a  mechanism for changing or redistributing the 
acyl chains in phospholipids as may be important in the control of membrane function 
(33, 36). Moreover, if increased phospholipase A activity is occurring, it could also be 
important in helping to establish communicative contacts between cells. The data of 
Hulser and Peters (37) indicates that free ionic flow is established between lymphocytes 
within  a  few  minutes  after  exposure  to  PHA.  They  have  speculated  that  this 
communication may be critical in the mitogenic response. While the mechanism by 
which these communications are established is uncertain,  increases in phospholipase 
activity  have  been  observed  in  acanthamoeba  castellanii  cells  when  intercellular 
communications are being established (38), raising the possibility of a similar role for 
this enzyme in  lectin-stimulated  lymphocytes. Thus, there are a  number of possible 
reasons why increases in phospholipase, or other lipolytic enzyme, activity might be 
important in lymphocyte activation. 
Summary 
After  exposure  to  mitogenic  lectins  in  vitro,  human  mononuclear  cells  (95% 
lymphocytes) that had been prelabeled with [14C]arachidonic acid rapidly released a 
portion of their radioactivity in the medium.  Most of the released radioactivity was 
demonstrated to be free arachidonic  acid.  Although  other sources are not  excluded, 
the most important source of cell-bound radioactivity in the release reaction appeared 
to be phosphatidylinositol,  suggesting that at  least part of the response is occurring 
through  an  increase  in  phospholipase  A2  activity.  By  gas  liquid  chromatography, 
other fatty acids were also shown to be released, but there was considerable selectivity 
in the response for arachidonic acid. The response was dependent on the availability 
of free  Ca  ++  in  the  medium  and  was  enhanced  by serum  proteins  and  unlabeled 
arachidonic  acid.  Most of the response appeared to be from the lymphocytes them- 
selves rather than from contaminating cells. 
The  rapid  generation  of free  arachidonic  acid  in  response  to  mitogenic  lectins 
suggests a  possible role for arachidonic acid metabolites in the activation process. 
Received  for publication 22January  1979. 
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